Reportlinker.com

Reportlinker.com

September 15, 2008 08:11 ET

High Growth Reported for the World Insulin Pumps (External) Market

LONDON, UNITED KINGDOM--(Marketwire - Sept. 15, 2008) -

Reportlinker.com announces that a new market research report related to the Cardiovascular diseases industry is available in its catalogue.

World Insulin Pumps (External) Market

http://www.reportlinker.com/p092486/World-Insulin-Pumps-(External)--Market.htm

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 18 companies including many key and niche players worldwide such as Animas Corporation, Debiotech S.A., Disetronic Medical Systems AG, Insulet Corporation, Matria Healthcare, Inc., Medtronic Diabetes, Nilimedix Ltd, Nipro Diabetes Systems, Smiths Medical MD, Inc., Sooil Development Co. Ltd., and Starbridge Systems. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.



INSULIN PUMPS (EXTERNAL) MCP-1511 
A GLOBAL STRATEGIC BUSINESS REPORT 

CONTENTS 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 
Study Reliability and Reporting Limitations I-1 
Disclaimers I-2 
Data Interpretation & Reporting Level I-2 
Quantitative Techniques & Analytics I-3 
Product Definitions and Scope of Study I-3 


II. EXECUTIVE SUMMARY 

1. Industry Overview II-1 
Current and Future Analysis II-1 
Competitive Scenario II-1 
Tough Ground for New Entrants II-1 
Major Growth Drivers II-2 
Developments in Insulin Delivering Technologies II-2 
ICR: A Key Factor to Success II-2 
Emergence of Combination Products II-3 
Expiry of Warranty Provides New Opportunities II-3 
Customer Satisfaction II-3 
Issues and Trends II-3 
Debate On Superiority of Pump Therapy Over MDI Continues II-3 
Complicated Software Poses a Threat II-3 
Lack of Awareness Limits Intensive Insulin Therapy Practice II-3 
Teenagers Outdo Adults in Controlling Diabetes II-4 

2. Diabetes & Insulin - An Abstract II-5 
Diabetes II-5 
A Fatal Disease II-5 
Table 1: Leading Countries Worldwide in Terms of Diabetes 
Population (includes corresponding Graph/Chart) II-5 
Types of Diabetes II-5 
Long Term Complications of Diabetes II-5 
Testing Sugar Levels: Easy and Accurate II-6 
Key Drug Classes of Diabetes II-6 
Insulin II-6 
Pancreas: The Main Source of Insulin in Human Body II-6 
Types of Insulin II-6 
Insulin Delivery Systems II-6 
a. Syringes II-6 
b. Insulin Pens II-7 
c. Jet Injectors II-7 
d. Tablets II-7 
e. External Insulin Pumps II-7 
Insulin Delivery Technologies II-7 

3. Product Overview II-8 
An Introduction to Insulin Pumps II-8 
Insulin Pump - A Replica of Pancreas II-8 
Advantages II-8 
More Accurate and Consistent II-8 
Enhances Blood Sugar Control in Pediatric Patients II-8 
A Peek into Past II-8 
Components of Insulin Pump II-9 
How Does an Insulin Pump Work? II-9 
Insulin Pump Delivery Rates II-9 
Guidelines for Insulin Pump Usage II-10 
Risks Involved in the Usage of Insulin Pumps II-11 
Lantus: A Threat to Insulin Pump Manufacturers II-11 
Training: A Crucial Aspect in Insulin Pump Therapy II-12 
Centers for Medicare & Medicaid Services (CMS): Funding 
Organizations II-12 
Implantable Insulin Pumps: Emerging Technology in Insulin Pump 
Market II-12 

4. Product Innovations/Introductions II-13 
ROCHE Launches Accu-Chek Spirit II-13 
Smith Medical Launches Cozmo in China II-13 
Industrial Scholar Devises Wristwatch Insulin Pump II-13 
Medtronic Unveils Arabic Language Insulin Pump II-13 
Medtronic Launches New Diabetes Monitoring System II-13 
Debiotech Unveils Miniaturized Insulin Nanopump(TM) II-14 
Roche Diagnostics Introduces New Insulin Pump System II-14 
Medtronic Releases New Diabetes Device II-14 
SpectRx Unveils SimpleChoice Infusion Sets II-14 
Nipro Diabetes Unveils Amigo (R) Insulin Pump II-14 
SpectRx Introduces New Series of Insulin Pumps II-15 
New OmniPod Insulin Management System from Insulet II-15 
New1250 Insulin Pumps from Animas II-15 
Smiths Medical Launches Insulin Pumps in Germany II-15 
Becton, Dickinson Unveils the First Intelligent Pump II-15 
Medtronic Rolls Out New Pump Systems II-16 
Accu-Science Launches New Insulin Pumps in Ireland II-16 
New Insulin Pump Infusion Sets from SpectRx II-16 
Roche Expands Accu-Chek Product Line II-16 
Cozmo(R) Insulin Pump Technology from Smiths II-16 
Medtronic Unveils Paradigm 512 and 712 II-17 
SpectRx Launches Disposable Infusion Set II-17 

5. Recent Industry Activity II-18 
Animas Partners with DexCom II-18 
Insulet Inks Agreement with DexCom II-18 
Medtronic Partners with LifeScan II-18 
Phluid Corporation Inks Agreement with Syprosoft II-18 
Insulet Partners with Flextronics II-18 
Medco Absorbs PolyMedica II-18 
Debiotech Allies with STMicroelectronics II-19 
NiliMedix Seeks FDA Approval II-19 
NiliMedix Attains CE Approval II-19 
NationsHealth Pockets Diabetes Care & Education II-19 
SpectRx, Inc. Divests Insulin Pump Business II-19 
SpectRx Sells SimpleChoice Business II-19 
Medtronic Obtains FDA Clearance for MiniMed Paradigm(R) Diabetes 
Device II-19 
FDA Approves Smiths Medical's Updated CozMore System II-19 
Matria Healthcare Acquires CorSolutions II-20 
Johnson & Johnson Acquires Animas II-20 
MiniMed Signs an Agreement with Smiths Medical II-20 
Starbridge Collaborates with Medical House Products II-20 
Medtronic Extends Educational Support for Diabetes Management II-21 
ADA Calls the Government to Rescind Cuts to Maine Care II-21 
Insulet Partners with Solectron II-21 
Animas' IR 1250 Pump Gains FDA Approval II-21 
Nilimed Awaits Grant from Chief Scientist II-22 
Animas Recalls Its Newly Released Insulin Pumps II-22 
Animas Teams Up with Debiotech II-22 
Deltec Turns Into Smiths Medical II-22 
Smiths' Products Gain FDA Approval II-23 
Cigna Detaches Dana II-23 
Smiths Collaborates with TheraSense II-23 
Animas' Insulin Pumps Receive Nod from Health Canada II-23 
Smiths Partners with Abbott II-23 
Cleo 90 Receives FDA Approval II-24 
Animas' Insulin Pumps Receives the Approval of Israeli Government II-24 
Animas Relocates Headquarters II-24 
FDA Bans Disetronic in the US II-24 
Animas Expands II-24 
Medtronic Retracts Infusion Sets II-24 
Animas Acquires Cygnus II-25 
Novo Nordisk Signs an Agreement with Medtronic II-25 
Roche Acquires Disetronic II-25 

6. Focus on Key Players II-27 
Animas Corporation (USA) II-27 
Debiotech S.A. (Switzerland) II-27 
Disetronic Medical Systems AG (Switzerland) II-27 
Insulet Corporation (USA) II-27 
Matria Healthcare, Inc. (USA) II-28 
Medtronic Diabetes (USA) II-28 
Nilimedix Ltd (Israel) II-28 
Nipro Diabetes Systems (USA) II-28 
Smiths Medical MD, Inc. (USA) II-29 
Sooil Development Co. Ltd. (Korea) II-29 
Starbridge Systems Ltd. (UK) II-29 

7. Global Market Perspective II-30 
Table 2: World Recent Past, Current & Future Market Analysis 
for Insulin Pumps (External) by Geographic Region - US, 
Europe, and Rest of World Markets Independently Analyzed with 
Annual Sales Figures in US$ Million for Years 2000 through 
2010 (includes corresponding Graph/Chart) II-30 

Table 3: World Long-term Projections for Insulin Pumps 
(External) by Geographic Region - US, Europe, and Rest of 
World Markets Independently Analyzed with Annual Sales Figures 
in US$ Million for Years 2011 through 2015 (includes 
corresponding Graph/Chart) II-31 

Table 4: World 10-Year Perspective for Insulin Pumps by 
Geographic Region - Percentage Breakdown of Dollar Sales for 
US, Europe, and Rest of World Markets for2003, 2008 & 2012 
(includes corresponding Graph/Chart) II-31 


III. MARKET 

1. The United States III-1 
A.Market Analysis III-1 
Current and Future Analysis III-1 
A Major Market for Insulin Delivery Devices III-1 
Product Innovations/Developments III-1 
Strategic Corporate Developments III-4 
Key Players III-11 
Animas Corporation III-11 
Becton, Dickinson & Company III-12 
Insulet Corporation III-12 
Matria Healthcare, Inc. III-12 
Medtronic Diabetes III-12 
Nipro Diabetes Systems III-13 
PolyMedica Corp III-13 
Smiths Medical MD, Inc. III-13 
B.Market Analytics III-13 
Table 5: US Recent Past, Current & Future Market Analysis 
for Insulin Pumps (External) - Annual Sales Figures in US$ 
Million for Years 2000 through 2010 (includes corresponding 
Graph/Chart) III-13 

Table 6: US Long-term Projections for Insulin Pumps 
(External) - Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) III-14 

2. Europe III-15 
A.Market Analysis III-15 
Current and Future Analysis III-15 
B.Market Analytics III-16 
Table 7: European Recent Past, Current & Future Market 
Analysis for Insulin Pumps (External) by Geographic Region - 
France, Germany, UK, Italy, Spain, and Rest of Europe 
Markets Independently Analyzed with Annual Sales Figures in 
US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-16 

Table 8: European Long-term Projections for Insulin Pumps 
(External) by Geographic Region - France, Germany, UK, 
Italy, Spain, and Rest of Europe Markets Independently 
Analyzed with Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) III-17 

Table 9: European 10-Year Perspective for Insulin Pumps by 
Geographic Region - Percentage Breakdown of Dollar Sales for 
France, Germany, UK, Italy, Spain,and Rest of Europe Markets 
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-18 

2a. France III-19 
Market Analysis III-19 
Table 10: French Recent Past, Current & Future Market 
Analysis for Insulin Pumps (External) - Annual Sales Figures 
in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-19 

Table 11: French Long-term Projections for Insulin Pumps 
(External) - Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) III-20 

2b. Germany III-21 
A.Market Analysis III-21 
Current and Future Analysis III-21 
Product Launch III-21 
B.Market Analytics III-21 
Table 12: German Recent Past, Current & Future Market 
Analysis for Insulin Pumps (External) - Annual Sales Figures 
in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-21 

Table 13: German Long-term Projections for Insulin Pumps 
(External) - Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) III-22 

2c. The United Kingdom III-23 
A.Market Analysis III-23 
Current and Future Analysis III-23 
INPUT (The Insulin Pump Therapy Group) III-23 
NICE (National Institute of Clinical Excellence) III-23 
Strategic Corporate Developments III-24 
Starbridge Systems Ltd. - A Key Player III-24 
B.Market Analytics III-25 
Table 14: United Kingdom Recent Past, Current & Future 
Market Analysis for Insulin Pumps (External) - Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-25 

Table 15: United Kingdom Long-term Projections for Insulin 
Pumps (External) - Annual Sales Figures in US$ Million for 
Years 2011 through 2015 (includes corresponding Graph/Chart) III-25 

2d. Italy III-26 
A.Market Analysis III-26 
Table 16: Italian Recent Past, Current & Future Market 
Analysis for Insulin Pumps (External) - Annual Sales Figures 
in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-26 

Table 17: Italian Long-term Projections for Insulin Pumps 
(External) - Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) III-27 

2e. Spain III-28 
Market Analysis III-28 
Table 18: Spanish Recent Past, Current & Future Market 
Analysis for Insulin Pumps (External) - Annual Sales Figures 
in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-28 

Table 19: Spanish Long-term Projections for Insulin Pumps 
(External) - Annual Sales Figures in US$ Million for Years 
2011 through 2015 (includes corresponding Graph/Chart) III-29 

2f. Rest of Europe III-30 
A.Market Analysis III-30 
Current and Future Analysis III-30 
Product Innovations/Developments III-30 
Strategic Corporate Developments III-31 
Key Players III-31 
Debiotech S.A. (Switzerland) III-32 
Disetronic Medical Systems AG (Switzerland) III-32 
B.Market Analytics III-32 
Table 20: Rest of Europe Recent Past, Current & Future 
Market Analysis for Insulin Pumps (External) - Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-32 

Table 21: Rest of Europe Long-term Projections for Insulin 
Pumps (External) - Annual Sales Figures in US$ Million for 
Years 2011 through 2015 (includes corresponding Graph/Chart) III-33 

3. Rest of World III-34 
A.Market Analysis III-34 
Current and Future Analysis III-34 
Review of Select Countries/Regions III-34 
Canada III-34 
Asia-Pacific III-34 
Product Launches III-34 
Strategic Corporate Developments III-34 
Key Players III-35 
Nilimedix Ltd (Israel) III-35 
Sooil Development Co. Ltd. (Korea) III-35 
B.Market Analytics III-36 
Table 22: Rest of World Recent Past, Current & Future Market 
Analysis for Insulin Pumps by Product - External Insulin 
Pumps Market Independently Analyzed with Annual Sales 
Figures in US$ Million for Years 2000 through 2010 (includes 
corresponding Graph/Chart) III-36 

Table 23: Rest of World Long-term Projections for Insulin 
Pumps by Product - External Insulin Pumps Market 
Independently Analyzed with Annual Sales Figures in US$ 
Million for Years 2011 through 2015 (includes corresponding 
Graph/Chart) III-36 


IV. COMPETITIVE LANDSCAPE

To order this report:

World Insulin Pumps (External) Market

http://www.reportlinker.com/p092486/World-Insulin-Pumps-(External)--Market.htm

More market research reports here!

Contact Information